RAAS-话题@MedSci

#RAAS#

13篇内容 | 1861人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2256238, encodeId=d42c22562380e, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a> <a href='/topic/show?id=804312512e42' target=_blank style='color:#2F92EE;'>#天麻#</a> <a href='/topic/show?id=f07a1251280e' target=_blank style='color:#2F92EE;'>#抗高血压活性#</a> <a href='/topic/show?id=ed201251293b' target=_blank style='color:#2F92EE;'>#体外肠吸收成分#</a> <a href='/topic/show?id=89c61251304b' target=_blank style='color:#2F92EE;'>#体内血浆成分#</a>, objectTitle=J Ethnopharmacol：天麻治疗高血压的药效成分及分子机制：吸收成分、网络药理分析、分子对接及体内实验验证, objectType=article, longId=866835, objectId=e460866835aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240619/1718765515611_92910.jpg, objectUrl=/article/show_article.do?id=e460866835aa, replyNumber=0, likeNumber=37, createdTime=2025-03-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=e460866835aa, moduleTitle=J Ethnopharmacol：天麻治疗高血压的药效成分及分子机制：吸收成分、网络药理分析、分子对接及体内实验验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e460866835aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1315141, encodeId=17a41315141f2, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险, objectType=article, longId=731842, objectId=7c41e31842d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c41e31842d7, replyNumber=0, likeNumber=139, createdTime=2022-07-10, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c41e31842d7, moduleTitle=Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c41e31842d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315140, encodeId=15261315140ca, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=ARD：2021年欧洲风湿病学协会联盟/美国风湿病学会诊断和管理自身炎症I型干扰素病（CANDLE/PRAAS、SAVI和AGS）应考虑的要点, objectType=article, longId=723472, objectId=10a2e234729d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10a2e234729d, replyNumber=0, likeNumber=83, createdTime=2022-04-05, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10a2e234729d, moduleTitle=ARD：2021年欧洲风湿病学协会联盟/美国风湿病学会诊断和管理自身炎症I型干扰素病（CANDLE/PRAAS、SAVI和AGS）应考虑的要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10a2e234729d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315139, encodeId=aa72131513919, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Eur J Heart Fail：二肽基肽酶3，心衰患者RAAS系统拮抗途径的标志物, objectType=article, longId=209047, objectId=78be20904e1b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78be20904e1b, replyNumber=0, likeNumber=110, createdTime=2021-03-28, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78be20904e1b, moduleTitle=Eur J Heart Fail：二肽基肽酶3，心衰患者RAAS系统拮抗途径的标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78be20904e1b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315138, encodeId=8ae21315138b8, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=JACC：RAAS抑制剂不会增加COVID-19风险, objectType=article, longId=197696, objectId=675619e6960d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=675619e6960d, replyNumber=0, likeNumber=121, createdTime=2020-07-19, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=675619e6960d, moduleTitle=JACC：RAAS抑制剂不会增加COVID-19风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=675619e6960d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315137, encodeId=7c20131513eee, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Eur Heart J：心衰男性和女性血浆ACE2浓度差异以及RAAS抑制剂的作用, objectType=article, longId=194004, objectId=ca4e1940040c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca4e1940040c, replyNumber=0, likeNumber=92, createdTime=2020-05-13, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca4e1940040c, moduleTitle=Eur Heart J：心衰男性和女性血浆ACE2浓度差异以及RAAS抑制剂的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca4e1940040c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315136, encodeId=81ea13151361c, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂, objectType=article, longId=168523, objectId=50ba1685238b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50ba1685238b, replyNumber=0, likeNumber=101, createdTime=2019-06-17, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50ba1685238b, moduleTitle=高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50ba1685238b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315135, encodeId=ae2113151351c, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Heart：肥厚型心肌病患者预防房颤 RAASI崭露头角, objectType=article, longId=147529, objectId=ff0e14e529ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0e14e529ad, replyNumber=0, likeNumber=97, createdTime=2018-08-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0e14e529ad, moduleTitle=Heart：肥厚型心肌病患者预防房颤 RAASI崭露头角, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0e14e529ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315134, encodeId=9ce613151346b, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者心血管结局如何看你RAAS抑制治疗的应答如何, objectType=article, longId=141963, objectId=d5f8141963e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5f8141963e1, replyNumber=0, likeNumber=96, createdTime=2018-07-01, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5f8141963e1, moduleTitle=Diabetes Obes Metab：2型糖尿病患者心血管结局如何看你RAAS抑制治疗的应答如何, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5f8141963e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315133, encodeId=6afd1315133a7, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？, objectType=article, longId=131185, objectId=2e94131185d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e94131185d7, replyNumber=0, likeNumber=89, createdTime=2018-03-03, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e94131185d7, moduleTitle=Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e94131185d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315132, encodeId=83751315132da, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=JCEM：HIV感染者过度肥胖和代谢功能障碍与RAAS活化期间利钠肽降低有关, objectType=article, longId=129513, objectId=3f7a129513c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7a129513c1, replyNumber=0, likeNumber=111, createdTime=2018-02-11, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7a129513c1, moduleTitle=JCEM：HIV感染者过度肥胖和代谢功能障碍与RAAS活化期间利钠肽降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f7a129513c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315131, encodeId=73f0131513157, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？, objectType=article, longId=89242, objectId=f0b18924290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0b18924290, replyNumber=0, likeNumber=95, createdTime=2017-02-19, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0b18924290, moduleTitle=Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0b18924290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315130, encodeId=d8d91315130fa, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=LDE：限制钠盐增强RAAS抑制剂治疗糖尿病肾病疗效, objectType=article, longId=34552, objectId=c256345524c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c256345524c, replyNumber=0, likeNumber=85, createdTime=2014-05-14, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c256345524c, moduleTitle=LDE：限制钠盐增强RAAS抑制剂治疗糖尿病肾病疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c256345524c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1315129, encodeId=a721131512989, content=<a href='/topic/show?id=fd321505e00' target=_blank style='color:#2F92EE;'>#RAAS#</a>, objectTitle=邹云增：奥美沙坦更优化调节RAAS, objectType=article, longId=28726, objectId=368d28e264f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=368d28e264f, replyNumber=0, likeNumber=94, createdTime=2014-01-01, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=368d28e264f, moduleTitle=邹云增：奥美沙坦更优化调节RAAS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=368d28e264f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RAAS

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#RAAS# #天麻# #抗高血压活性# #体外肠吸收成分# #体内血浆成分#

J Ethnopharmacol：天麻治疗高血压的药效成分及分子机制：吸收成分、网络药理分析、分子对接及体内实验验证

2025-03-15发表于陕西省

venlin (审核中...)

前往app查看评论内容

#RAAS#

Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险

2022-07-10

venlin (审核中...)

前往app查看评论内容

#RAAS#

ARD：2021年欧洲风湿病学协会联盟/美国风湿病学会诊断和管理自身炎症I型干扰素病（CANDLE/PRAAS、SAVI和AGS）应考虑的要点

2022-04-05

venlin (审核中...)

前往app查看评论内容

#RAAS#

Eur J Heart Fail：二肽基肽酶3，心衰患者RAAS系统拮抗途径的标志物

2021-03-28

venlin (审核中...)

前往app查看评论内容

#RAAS#

JACC：RAAS抑制剂不会增加COVID-19风险

2020-07-19

venlin (审核中...)

前往app查看评论内容

#RAAS#

Eur Heart J：心衰男性和女性血浆ACE2浓度差异以及RAAS抑制剂的作用

2020-05-13

venlin (审核中...)

前往app查看评论内容

#RAAS#

高血压评估容量负荷建议：推荐评估吃盐量，**RAAS阻断剂+利尿剂

2019-06-17

zhaojie88 (审核中...)

前往app查看评论内容

#RAAS#

Heart：肥厚型心肌病患者预防房颤 RAASI崭露头角

2018-08-29

venlin (审核中...)

前往app查看评论内容

#RAAS#

Diabetes Obes Metab：2型糖尿病患者心血管结局如何看你RAAS抑制治疗的应答如何

2018-07-01

venlin (审核中...)

前往app查看评论内容

#RAAS#

Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？

2018-03-03

venlin (审核中...)

前往app查看评论内容

#RAAS#

JCEM：HIV感染者过度肥胖和代谢功能障碍与RAAS活化期间利钠肽降低有关

2018-02-11

venlin (审核中...)

前往app查看评论内容

#RAAS#

Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？

2017-02-19

venlin (审核中...)

前往app查看评论内容

#RAAS#

LDE：限制钠盐增强RAAS抑制剂治疗糖尿病肾病疗效

2014-05-14

venlin (审核中...)

前往app查看评论内容

#RAAS#

邹云增：奥美沙坦更优化调节RAAS

2014-01-01

科室
- - 订阅+
  - 更多科室
工具
服务